
Core Insights - Adient reported $3.66 billion in revenue for the quarter ended December 2023, a year-over-year decline of 1.1% [1] - The EPS for the same period was $0.31, down from $0.34 a year ago [1] - Revenue fell short of the Zacks Consensus Estimate of $3.72 billion, resulting in a surprise of -1.50% [1] - The company experienced an EPS surprise of -34.04%, with the consensus EPS estimate being $0.47 [1] Performance Metrics - Net Sales in Asia were $770 million, compared to an estimated $844.49 million, reflecting a year-over-year decline of -6.2% [2] - Net Sales from Eliminations were reported at -$25 million, better than the estimated -$32.69 million, with a year-over-year change of -10.7% [2] - Net Sales in America reached $1.65 billion, slightly above the estimated $1.64 billion, showing a year-over-year decline of -4.5% [2] - Net Sales in EMEA were $1.27 billion, exceeding the estimated $1.25 billion, with a year-over-year increase of +7.3% [2] Stock Performance - Adient shares returned +4.7% over the past month, compared to the Zacks S&P 500 composite's +5.6% change [2] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [2]